Postpartum Haemorrhage (PPH)

Knowledge Check

Exam-style MCQs aligned with these notes. Available to Hyperexcision Scholar members.

Log in to access
Last updated: June 26, 2026Bookmark

Postpartum haemorrhage (PPH) is defined as blood loss associated with signs and symptoms of hypovolemia, regardless of the mode of delivery.

Historically, it was defined as:

  1. Blood loss > 500 mL in vaginal delivery
  2. Blood loss > 1000 mL in caeserian delivery

It is an obstetric emergency. A mother can rapidly exsanguinate from PPH since blood flow to the uterus is increased to a rate of ~700 mL/minute, from ~100 mL/minute in the non-pregnant state.

Classification of postpartum haemorrhage

ClassificationDescription
Primary (early) PPHOccurs from delivery of the placenta to 24 hours postpartum
Late PPHOccurs between 24 hours and 12 weeks postpartum

Causes of PPH: The 4 T’s

ToneTraumaTissueThrombin
ExamplesUterine atonyCervical, vaginal or perineal lacerations, uterine rupture, and uterine inversionRetained placenta, retained products of conception, and placenta accretaDIC, HELLP, Von-Willebrand disease
Risk factorsPrecipitous labour, overdistended uterusUncontrolled labourAccessory lobe or abnormal placentationAbruptio placentae
DiagnosisSoft and boggy uterusVisual inspection – bright-red blood in the presence of a well-contracted uterusPelvic ultrasoundBleeding in other sites, laboratory abnormalities
TreatmentUterotonics, mechanical, and surgical methodsRepair of tears and tranexamic acidManual removal, ultrasound guided removalICU care and blood products
  • Assessment of blood loss
    • Visual estimation
    • Graduated drapes
    • Weighing soaked swabs/sponges
    • Measuring suction canisters
    • Serial measurement of vital signs
  • Investigations
    • Complete blood count
    • Group and crossmatch
    • PT or INR
    • aPTT
    • Fibrinogen
    • Urea and Creatinine
    • Blood gas analysis
    • Lactate levels
    • Ultrasound for retained placenta or products of conception
  • Treatment
    • Resuscitation
      • Oxygen if indicated
      • Insert bilateral wide-bore IV catheters
      • IV fluids
      • Blood tranfusion (massive blood tranfusion may be required)
      • Tranexamic acid (TXA)
      • Foley catheter to decompress the bladder and measure urine output. A relaxed bladder allows the lower uterine segment to contract, and facilitates uterine massage and compression
      • Order investigations: CBC group and crossmatch, and coagulation panel
    • Rule out lacerations
    • Uterine massage
    • Uterotonics
    • Bimanual compression
    • Manual removal of retained placenta or products of conception
    • Balloon tamponade
    • Surgery (laparatomy)
      • Uterine compression sutures
      • Devascularization: uterine artery ligation → internal iliac artery ligations
      • Subtotal hysterectomy
  • Complications
  • Prevention
    • Healthy practices before to labour
      • Prevention, early detection, and treatment of anaemia
      • Early detection and management of vaginal bleeding problems
      • Complication-readiness preparations.
    • Active management of the third stage of labour (AMTSL)
      • Intramuscular oxytocin within 1 minute of delivering the child
      • Controlled Cord Traction (CCT) and Counter-pressure to the uterus (Modified Brandt-Andrew Maneuver)
      • Uterine massage after delivery of the placenta.
    • Palpate the uterus every 15 minutes for 2 hours to make sure it is firm.
    • Monitor the amount of bleeding
    • Prevent prolonged labor
    • Prevent dehydration
    • Early detection and management of vaginal bleeding problems
    • Avoiding vaginal/perineal trauma
Reference Intervals
Biochemistry
ACTHP: <80 ng/L
ALTP: 5–35 U/L
AlbuminP: 35–50 g/L
AldosteroneP: 100–500 pmol/L
Alk. phosphataseP: 30–130 U/L
α-AmylaseP: 0–180 IU/dL
α-FetoproteinS: <10 kU/L
Angiotensin IIP: 5–35 pmol/L
ADHP: 0.9–4.6 pmol/L
ASTP: 5–35 U/L
BicarbonateP: 24–30 mmol/L
BilirubinP: 3–17 μmol/L
BNPP: <50 ng/L
CRPP: <10 mg/L
CalcitoninP: <0.1 mcg/L
Calcium (ionized)P: 1.0–1.25 mmol/L
Calcium (total)P: 2.12–2.60 mmol/L
ChlorideP: 95–105 mmol/L
CholesterolP: <5.0 mmol/L
VLDLP: 0.128–0.645 mmol/L
LDLP: <2.0 mmol/L
HDLP: 0.9–1.93 mmol/L
Cortisol AMP: 450–700 nmol/L
Cortisol MidnightP: 80–280 nmol/L
CK ♂P: 25–195 U/L
CK ♀P: 25–170 U/L
CreatinineP: 70–100 μmol/L
FerritinP: 12–200 mcg/L
FolateS: 2.1 mcg/L
FSHP: 2–8 U/L ♂; >25 menopause
GGT ♂P: 11–51 U/L
GGT ♀P: 7–33 U/L
Glucose (fasting)P: 3.5–5.5 mmol/L
Growth hormoneP: <20 mu/L
HbA1C (DCCT)B: 4–6%
HbA1C (IFCC)B: 20–42 mmol/mol
Iron ♂S: 14–31 μmol/L
Iron ♀S: 11–30 μmol/L
Lactate (venous)P: 0.6–2.4 mmol/L
Lactate (arterial)P: 0.6–1.8 mmol/L
LDHP: 70–250 U/L
LHP: 3–16 U/L
MagnesiumP: 0.75–1.05 mmol/L
OsmolalityP: 278–305 mosmol/kg
PTHP: 0.8–8.5 pmol/L
PotassiumP: 3.5–5.3 mmol/L
Prolactin ♂P: <450 U/L
Prolactin ♀P: <600 U/L
PSAP: 0–4 mcg/mL
Protein (total)P: 60–80 g/L
Red cell folateB: 0.36–1.44 μmol/L
Renin (erect)P: 2.8–4.5 pmol/mL/h
Renin (recumbent)P: 1.1–2.7 pmol/mL/h
SodiumP: 135–145 mmol/L
TBGP: 7–17 mg/L
TSHP: 0.5–4.2 mU/L
T4P: 70–140 nmol/L
Free T4P: 9–22 pmol/L
TIBCS: 54–75 μmol/L
TriglyceridesP: 0.50–2.3 mmol/L
T3P: 1.2–3.0 nmol/L
Troponin TP: <0.1 mcg/L
Urate ♂P: 210–480 μmol/L
Urate ♀P: 150–390 μmol/L
UreaP: 2.5–6.7 mmol/L
Vitamin B12S: 0.13–0.68 nmol/L
Vitamin DS: 50 nmol/L
Arterial Blood Gases
pH7.35–7.45
PaCO₂4.7–6.0 kPa
PaO₂>10.6 kPa
Base excess±2 mmol/L
Urine
Cortisol (free)<280 nmol/24h
Hydroxyindole acetic acid16–73 μmol/24h
Hydroxymethylmandelic acid16–48 μmol/24h
Metanephrines0.03–0.69 μmol/mmol cr.
Osmolality350–1000 mosmol/kg
17-Oxogenic steroids ♂28–30 μmol/24h
17-Oxogenic steroids ♀21–66 μmol/24h
17-Oxosteroids ♂17–76 μmol/24h
17-Oxosteroids ♀14–59 μmol/24h
Phosphate (inorganic)15–50 mmol/24h
Potassium14–120 mmol/24h
Protein<150 mg/24h
Protein/creatinine ratio<3 mg/mmol
Sodium100–250 mmol/24h
Haematology
WCC4.0–11.0 ×10⁹/L
RBC ♂4.5–6.5 ×10¹²/L
RBC ♀3.9–5.6 ×10¹²/L
Hb ♂130–180 g/L
Hb ♀115–160 g/L
PCV ♂0.4–0.54 L/L
PCV ♀0.37–0.47 L/L
MCV76–96 fL
MCH27–32 pg
MCHC300–360 g/L
RDW11.6–14.6%
Neutrophils2.0–7.5 ×10⁹/L (40–75%)
Lymphocytes1.0–4.5 ×10⁹/L (20–45%)
Eosinophils0.04–0.44 ×10⁹/L (1–6%)
Basophils0–0.10 ×10⁹/L (0–1%)
Monocytes0.2–0.8 ×10⁹/L (2–10%)
Platelets150–400 ×10⁹/L
Reticulocytes0.8–2.0% / 25–100 ×10⁹/L
Prothrombin time10–14 s
APTT35–45 s
Paediatric
Pulse Rate (bpm)
Neonate140–160
Infant <1yr120–140
1–5 years110–130
5–12 years80–120
>12 years70–100
Respiratory Rate (tachypnoea)
0–2 months≥60/min
2–12 months≥50/min
1–5 years≥40/min
>5 years≥30/min
Blood Pressure (mmHg)
Term65/45
1 year75/50
4 years85/60
8 years95/65
10 years100/70
Weight Formulas
3–12 months(a + 9)/2 kg
1–6 years2a + 8 kg
>6 years(7a − 5)/2 kg
Haemoglobin (g/dL)
Term newborn13–20
1 month11–18
2 months10–15
1–2 years10–13
>2 years11–14
MUAC (6 months–5 years)
Obese>17.5 cm
Normal13.5–17.4 cm
At risk12.5–13.4 cm
Moderate malnutrition11.5–12.4 cm
Severe malnutrition<11.5 cm
Developmental Milestones
Social smile1.5 months
Head control4 months
Sits unsupported7 months
Crawls10 months
Stands unsupported10–12 months
Walks12–13 months
Talks18 months
CSF WBC (/mm³)
Term newborn0–25
>2 weeks0–5
Calculator

Leave a Reply

A moment of your time
Step 1 of 2

You are the reason this exists. Got 60 seconds? Help us improve Hyperexcision for every medical student who uses it.

The Hyperexcision Team